Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Producing, Controlling, and Stabilizing Pasteur's Anthrax Vaccine

Creating a New Industry and a Health Market

Bibliographic Data

ID4516590
AuthorsMaurice Cassier (0000-0003-3908-8073, corresponding author)
Year2008
Volume21
Issue2
Pages253-278
Publication date2008-06-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenueScience in Context (JOURNAL)
Journal identifiersISSN: 0269-8897 • E-ISSN: 1474-0664
PublisherCambridge University Press (CUP) (PUBLISHER)
DOI10.1017/s0269889708001713
PMID18831139
OpenAlexW2138400530
LanguageEN
Citations received4
References cited11

ArgumentWhen Pasteur and Chamberland hastily set up their small biological industry to meet the agricultural demand for the anthrax vaccine, their methods for preparation and production had not yet been stabilized. The process of learning how to standardize biological products was accelerated in 1882 when vaccination accidents required the revision of production norms as the first hypotheses on fixity, inalterability, and transportability of vaccines were invalidated and replaced by procedures for continuous monitoring of the calibration of vaccines and the renewal of vaccine strains. Initially, the incompleteness and ongoing development of production standards justified Pasteur's monopoly on the production of the anthrax vaccine under his immediate supervision. Later on, the Pasteur Institute maintained control of these standards in the framework of a commercial monopoly that it established on the veterinary vaccines first sent and then cultivated abroad by the Société de Vulgarisation du Vaccin Charbonneux Pasteur, founded in 1886

Anthrax vaccines · Biology · Business · Economics · Immunization · Monopoly · Vaccination · Historical Medical Research and Treatments · Historical Studies and Socio-cultural Analysis · History of Science and Medicine · Medicine · Biotechnology · Immunology · Virology

  • Institutional enterprise as a compromise

    Gabriel Galvez-Behar•Management & Organizational History•2017

  • Commercializing science

    Joris Mercelis, Gabriel Galvez-Behar et al.•History and Technology•2017

  • Dilemmas of a Vitalizing Vaccine Market

    Open Access•Fredrik Bragesjö, Margareta Hallberg•Science in Context•2011

  • A pasteurização do império francês

    Open Access•Matheus Alves Duarte Da Silva•História Ciências Saúde-Manguinhos•2020

  • The Economic Implications of Learning by Doing

    Kenneth J Arrow•The Review of Economic Studies•1962

  • Inside the Black Box

    Open Access•Nathan Rosenberg•Inside the Black Box•1983

  • Is Science a Public Good? Fifth Mullins Lecture, Virginia Polytechnic Institute, 23 March 1993

    Open Access•Michel Callon•Science Technology & Human Values•1994

  • Making the Unit of Insulin

    Christiane Sinding•Bulletin of the history of medicine•2002

  • Appropriation and commercialization of the Pasteur anthrax vaccine

    Open Access•Maurice Cassier•Studies in History and Philosophy…•2005

  • On hybridizations, networks and new disciplines

    Open Access•Ilana Löwy•Studies in History and Philosophy…•1994

  • Pasteur et la revolution pastorienne

    Pierre Guillaume, Claire Salomon-Bayet•Vingtième Siècle Revue d histoire•1987

Unique citing works4
Citations per year0,27
Citation span2011 - 2020 (10)
Citation velocityhistorical
Highly citedNo
Citation typesNeutral: 4

Tools

Open DOISci-HubOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae